Sascha Bucher
Board Member

Mr. Sascha Bucher is co-founder and Partner at Forty51 ventures, a Biotech VC fund in Europe focused on venture formation. Previously, he was Partner and Managing Director Investments at Roivant Sciences and Head of Europe. Before that Sascha worked for Roche in numerous Business and Corporate Development functions including as Deputy Head of Global M&A. He was involved in 100+ transactions and negotiated and closed over 50 international deals with an accumulated total deal value of more than 10 billion USD. Prior to Roche, Sascha was a banker at UBS. He is a Board member of several Biotech companies including Tarsier Pharma and Altavant Sciences. Sascha holds an MBA in Finance and Economics from the University of Basel and is both a Harvard Business School GMP alumnus and a Certified European Financial Analyst and Asset Manager (CEFA).

Meet the whole team

TYPE & ENTER: